

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1286, 2001-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Enalapril/Nitrendipine: ENEAS, Nitrendipine/Enalapril
Drugs in R&D, Vol. 3, Iss. 2, 2002-02 ,pp. :


Olmesartan, nitrendipine similar in hypertension
Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. :


Nitrendipine plus enalapril: additive antihypertensive effects
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :


Renoprotective Therapy in Patients With Nondiabetic Nephropathies
By Pisoni R.
Drugs, Vol. 61, Iss. 6, 2001-01 ,pp. :